RE:This is exactly like other pharma offeringsWhat if the offering is oversubscribed by a factor of 2 or 3 times ? Some PP participants who sold their existing holdings or sold short may need to scramble to buy/cover. Considering what a steal the PP pricing is, it is a possibility. All you need is one hedge fund to get what Theralase is about and ask to fill the whole $15 million themselves.
cobblehill wrote: Mackie has a stable of past pharma offerings, some where there were 5 yr warrants and 40% sp drops afterwards
I found those listed on their website when the offering first posted. Because of that knowledge, I was better prepared for this outcome.
If the warrant is worth .02 to you, sell your shares and buy the offering. Seriously, what's the hard part? That's why the price is in the toilet, current investors are doing the smart thing.
This offering probably closes by the 8th,oversubscribed. This is a gift in my opinion.